trihexyphenidyl has been researched along with ARSA Deficiency in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Thirty-seven per cent of the 35 idiopathic dystonia patients had a moderate to marked improvement with an average dosage of 21." | 1.27 | High dose anticholinergic therapy in adult dystonia. ( Lang, AE, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lang, AE | 1 |
1 other study available for trihexyphenidyl and ARSA Deficiency
| Article | Year |
|---|---|
High dose anticholinergic therapy in adult dystonia.
Topics: Adolescent; Adult; Benztropine; Drug Evaluation; Dystonia; Humans; Leukodystrophy, Metachromatic; Mi | 1986 |